Abstract:BACKGROUND: The chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like gene (CHD1L) is a recently identified oncogene localized at 1q21. CHD1L protein over-expression in primary hepatocellular carcinoma is correlated with enhanced apoptosis inhibition, reduced chemosensitivity and shortened patient survival. However, CHD1L protein status or mRNA expression in breast cancer and its clinical significance remain obscure.MATERIAL AND METHODS: In this study, immunohistochemical staining for CHD1L expression was performed on tissue microarrays containing 179 primary invasive breast cancers and 65 matched normal breast tissue specimens. Clinico-pathological features were collected and compared between different CHD1L statuses. Kaplan-Meier curves were applied to estimate disease-free survival (DFS) and overall survival (OS). Cox regression was used to identify independent prognostic factors. Also, quantitative real-time polymerase chain reaction (QRT-PCR) was employed to evaluate the mRNA level expression of CHD1L in six breast cancer cell lines.RESULTS: Presence of CHD1L over-expression was observed in 87 of the 179 patients (48.6%), which associated with a younger age (P = 0.011), higher grade (P = 0.004), higher Ki-67 index (P = 0.018) and HER2 over-expression/amplification (P = 0.037). After a median follow-up of 55 months, patients with presence of CHD1L over-expression had significantly poorer DFS (82.6% Vs 76.3%, P = 0.035), but not OS (87.0% Vs 94.9%, P = 0.439). In multivariate analysis, CHD1L status (HR = 2.169, [95%CI, 1.029-4.573], P = 0.042), triple negative subtype (HR = 2.809, [95%CI 1.086-7.264], P = 0.033) and HER2 positive subtype (HR = 5.221, [95%CI 1.788-15.240], P = 0.002) were identified as independent prognostic factors for DFS. In vitro study indicated that relative mRNA expression level of CHD1L was higher in breast cancer cell lines, especially in MDA-MB-231 and LM2-4175, when compared to normal breast epithelial cell line.CONCLUSIONS: Presence of CHD1L over-expression is probably associated with aggressive tumor biology in breast cancer. CHD1L status might be a novel prognostic biomarker for patients with breast cancer.

CHD1L Promotes Hepatocellular Carcinoma Progression and Metastasis in Mice and is Associated with These Processes in Human Patients.

CHI3L1 Promotes Tumor Progression by Activating TGF-β Signaling Pathway in Hepatocellular Carcinoma.

CLIC1 Drives Angiogenesis in Hepatocellular Carcinoma by Modulating VEGFA

Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer

Transgenic CHD1L Expression in Mouse Induces Spontaneous Tumors

Chd1l Promotes Tumor Progression and Predicts Survival in Colorectal Carcinoma

CHD1L Promotes Lineage Reversion of Hepatocellular Carcinoma Through Opening Chromatin for Key Developmental Transcription Factors.

CHD1L Promotes EOC Cell Invasiveness and Metastasis Via the Regulation of METAP2

Overexpression of CHD1L is Positively Associated with Metastasis of Lung Adenocarcinoma and Predicts Patients Poor Survival

Chromodomain Helicase/adenosine Triphosphatase DNA Binding Protein 1-Like (chd1l) Gene Suppresses the Nucleus-to-mitochondria Translocation of Nur77 to Sustain Hepatocellular Carcinoma Cell Survival.

Overexpression of N-terminal Kinase Like Gene Promotes Tumorigenicity of Hepatocellular Carcinoma by Regulating Cell Cycle Progression and Cell Motility

CHD1L Promotes Cell Cycle Progression and Cell Motility by Up-Regulating MDM2 in Breast Cancer.

Overexpression Of Chd1l Is Associated With Poor Survival And Aggressive Tumor Biology In Esophageal Carcinoma

Identification of CCDC115 As an Adverse Prognostic Biomarker in Liver Cancer Based on Bioinformatics and Experimental Analyses

Translationally Controlled Tumor Protein Induces Mitotic Defects and Chromosome Missegregation in Hepatocellular Carcinoma Development

Loss of LIMCH1 Predicts Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics

Increased Long Noncoding RNA LASP1‐AS is Critical for Hepatocellular Carcinoma Tumorigenesis Via Upregulating LASP1

HN1L-mediated Transcriptional Axis AP-2γ/METTL13/TCF3-ZEB1 Drives Tumor Growth and Metastasis in Hepatocellular Carcinoma.

Transcription factor EHF drives cholangiocarcinoma development through transcriptional activation of glioma-associated oncogene homolog 1 and chemokine CCL2

Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer

CHD1L Regulates Cell Cycle, Apoptosis, and Migration in Glioma